INVESTOR ALERT: Investigation of Spectrum Pharmaceuticals, Inc. Announced by Law Offices of Howard G. Smith
September 23 2016 - 11:23AM
Business Wire
Law Offices of Howard G. Smith announces an investigation
on behalf of investors of Spectrum Pharmaceuticals, Inc.
(“Spectrum” or the “Company”) (NASDAQ: SPPI) concerning the Company
and its officers’ possible violations of federal securities
laws.
The investigation concerns whether the Company misled investors
regarding the FDA’s inquiry into whether data from the Spectrum 611
and 612 Studies were clinically meaningful; and whether the FDA
advised defendants in December 2012 not to submit the New Drug
Application based on data from the 611 and 612 Studies. Following
the Company’s announcement that the FDA had denied approval for its
apaziquone NDA the Company’s shares fell sharply in value.
If you purchased Spectrum securities, have information or would
like to learn more about these claims, or have any questions
concerning this announcement or your rights or interests with
respect to these matters, please contact Howard G. Smith, Esquire,
of Law Offices of Howard G. Smith, 3070 Bristol Pike, Suite 112,
Bensalem, Pennsylvania 19020 by telephone at (215) 638-4847,
toll-free at (888) 638-4847, or by email
to howardsmith@howardsmithlaw.com, or visit our website at
http://www.howardsmithlaw.com.
This press release may be considered Attorney Advertising in
some jurisdictions under the applicable law and ethical rules.
View source
version on businesswire.com: http://www.businesswire.com/news/home/20160923005601/en/
Law Offices of Howard G. SmithHoward G. Smith,
Esquire215-638-4847888-638-4847howardsmith@howardsmithlaw.comwww.howardsmithlaw.com
Spectrum Pharmaceuticals (NASDAQ:SPPI)
Historical Stock Chart
From Mar 2024 to Apr 2024
Spectrum Pharmaceuticals (NASDAQ:SPPI)
Historical Stock Chart
From Apr 2023 to Apr 2024